Neurology & Movement Disorders
Essential Tremor Clinical Research
Essential Tremor (ET) is one of the most common neurological movement disorders, affecting millions of individuals worldwide. CenExel partners with sponsors to advance innovative therapies focused on reducing tremors, improving motor control, and enhancing quality of life for adult and aging populations living with Essential Tremor.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Research for Essential Tremor Treatments
CenExel provides specialized clinical trial expertise in neurological and movement disorder research, supporting innovative therapies for Essential Tremor. Our experienced investigators, operational teams, and patient recruitment specialists help sponsors execute trials efficiently from early-phase development through late-stage studies.
Conditions Covered
Essential Tremor Conditions We Research
Our neurology research teams support studies across a broad range of movement disorders and neurological conditions.
- Essential Tremor
- Parkinsonian Tremor
- Upper Limb Tremor
- Hand Tremor Disorders
- Action Tremor
- Resting Tremor
- Movement Disorders
- Neurological Motor Disorders
Our Approach
Why Sponsors Choose CenExel for Essential Tremor Research
CenExel provides scientific expertise, rapid enrollment strategies, and operational excellence for neurological clinical trials.
01
Experienced Neurology Teams
Our investigators have extensive experience managing neurological and movement disorder studies.
02
Advanced Patient Recruitment
Targeted outreach and database-driven recruitment strategies improve enrollment timelines.
03
Diverse Patient Populations
Access to broad and diverse patient populations across multiple U.S. research sites.
04
High-Quality Clinical Data
Dedicated site staff and centralized oversight ensure consistent and reliable trial execution.
Phase Coverage
Supported Essential Tremor Trial Phases
CenExel supports early and late-phase neurological research — from first-in-human studies through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our experienced clinical research teams support biomarker-driven studies, CNS-focused protocols, and long-term neurological outcome tracking across multiple therapeutic programs.
Neurology Task Force
CenExel supports a wide range of neurological and movement disorder studies with experienced investigators, specialized patient populations, and operational expertise across multiple sites.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
